EU Expands Use of Roche's Pegasys in Chronic Hepatitis C

Roche said on Monday the European Medicines Agency has expanded the approval of its drug Pegasys plus ribavirin for the treatment of chronic hepatitis C virus to children five years of age and older.
Yahoo! News